These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Facilitated expansion of Th17 cells in lupus nephritis patients. Jakiela B; Kosałka J; Plutecka H; Bazan-Socha S; Sanak M; Musiał J Clin Exp Immunol; 2018 Dec; 194(3):283-294. PubMed ID: 30086206 [TBL] [Abstract][Full Text] [Related]
4. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis. AlFadhli S; AlFailakawi A; Ghanem AA Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163 [TBL] [Abstract][Full Text] [Related]
5. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Xing Q; Wang B; Su H; Cui J; Li J Rheumatol Int; 2012 Apr; 32(4):949-58. PubMed ID: 21243492 [TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus]. Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966 [TBL] [Abstract][Full Text] [Related]
7. Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response. Enghard P; Rieder C; Kopetschke K; Klocke JR; Undeutsch R; Biesen R; Dragun D; Gollasch M; Schneider U; Aupperle K; Humrich JY; Hiepe F; Backhaus M; Radbruch AH; Burmester GR; Riemekasten G Ann Rheum Dis; 2014 Jan; 73(1):277-83. PubMed ID: 23475982 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance. Fu D; Senouthai S; Wang J; You Y BMC Nephrol; 2019 Sep; 20(1):350. PubMed ID: 31488076 [TBL] [Abstract][Full Text] [Related]
9. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus. Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258 [TBL] [Abstract][Full Text] [Related]
10. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis. Kshirsagar S; Riedl M; Billing H; Tönshoff B; Thangavadivel S; Steuber C; Staude H; Wechselberger G; Edelbauer M J Immunol; 2014 Nov; 193(10):4895-903. PubMed ID: 25339666 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-10a-3p mediates Th17/Treg cell balance and improves renal injury by inhibiting REG3A in lupus nephritis. You G; Cao H; Yan L; He P; Wang Y; Liu B; Shao F Int Immunopharmacol; 2020 Nov; 88():106891. PubMed ID: 32853927 [TBL] [Abstract][Full Text] [Related]
12. Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus. Handono K; Firdausi SN; Pratama MZ; Endharti AT; Kalim H Clin Rheumatol; 2016 Mar; 35(3):631-8. PubMed ID: 26852315 [TBL] [Abstract][Full Text] [Related]
13. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Chen DY; Chen YM; Wen MC; Hsieh TY; Hung WT; Lan JL Lupus; 2012 Nov; 21(13):1385-96. PubMed ID: 22892208 [TBL] [Abstract][Full Text] [Related]
14. Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus. Chu Y; Zhao C; Zhang B; Wang X; Wang Y; An J; Chen J Lupus; 2019 Oct; 28(12):1397-1406. PubMed ID: 31551029 [TBL] [Abstract][Full Text] [Related]
15. Increase of peripheral T regulatory cells during remission induction with cyclophosphamide in active systemic lupus erythematosus. Tselios K; Sarantopoulos A; Gkougkourelas I; Papagianni A; Boura P Int J Rheum Dis; 2014 Sep; 17(7):790-5. PubMed ID: 25430593 [TBL] [Abstract][Full Text] [Related]
16. IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. Zickert A; Amoudruz P; Sundström Y; Rönnelid J; Malmström V; Gunnarsson I BMC Immunol; 2015 Feb; 16(1):7. PubMed ID: 25887118 [TBL] [Abstract][Full Text] [Related]
17. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells. Yao L; Chen HP; Ma Q Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470 [TBL] [Abstract][Full Text] [Related]
18. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis. Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776 [TBL] [Abstract][Full Text] [Related]
19. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial. Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558 [TBL] [Abstract][Full Text] [Related]
20. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]